Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Examining the Unit Costs of COVID-19 Vaccine Delivery in Kenya

View through CrossRef
ABSTRACT Introduction Vaccines are considered the path out of the COVID-19 pandemic. The government of Kenya is implementing a phased strategy to vaccinate the Kenyan population, initially targeting populations at high risk of severe disease and infection. We estimated the financial and economic unit costs of procuring and delivering the COVID-19 vaccine in Kenya across various vaccination strategies. Methods We used an activity-based costing approach to estimate the incremental costs of COVID-19 vaccine delivery, from a health systems perspective. Document reviews and key informant interviews (n=12) were done to inform the activities, assumptions and the resources required. Unit prices were derived from document reviews or from market prices. Both financial and economic vaccine procurement costs per person vaccinated with 2-doses, and the vaccine delivery costs per person vaccinated with 2-doses were estimated and reported in 2021USD. Results The financial costs of vaccine procurement per person vaccinated with 2-doses ranged from $2.89-$13.09 in the 30% and 100% coverage levels respectively, however, the economic cost was $17.34 across all strategies. Financial vaccine delivery costs per person vaccinated with 2-doses, ranged from $4.28-$3.29 in the 30% and 100% coverage strategies: While the economic delivery costs were two to three times higher than the financial costs. The total procurement and delivery costs per person vaccinated with 2-doses ranged from $7.34-$16.47 for the financial costs and $29.7-$24.68 for the economic costs for the 30% and 100% coverage respectively. With the exception of procurement costs, the main cost driver of financial and economic delivery costs was supply chain costs (47-59%) and advocacy, communication and social mobilization (29-35%) respectively. Conclusion This analysis presents cost estimates that can be used to inform local policy and may further inform parameters used in cost-effectiveness models. The results could potentially be adapted and adjusted to country-specific assumptions to enhance applicability in similar low-and middle-income settings.
Title: Examining the Unit Costs of COVID-19 Vaccine Delivery in Kenya
Description:
ABSTRACT Introduction Vaccines are considered the path out of the COVID-19 pandemic.
The government of Kenya is implementing a phased strategy to vaccinate the Kenyan population, initially targeting populations at high risk of severe disease and infection.
We estimated the financial and economic unit costs of procuring and delivering the COVID-19 vaccine in Kenya across various vaccination strategies.
Methods We used an activity-based costing approach to estimate the incremental costs of COVID-19 vaccine delivery, from a health systems perspective.
Document reviews and key informant interviews (n=12) were done to inform the activities, assumptions and the resources required.
Unit prices were derived from document reviews or from market prices.
Both financial and economic vaccine procurement costs per person vaccinated with 2-doses, and the vaccine delivery costs per person vaccinated with 2-doses were estimated and reported in 2021USD.
Results The financial costs of vaccine procurement per person vaccinated with 2-doses ranged from $2.
89-$13.
09 in the 30% and 100% coverage levels respectively, however, the economic cost was $17.
34 across all strategies.
Financial vaccine delivery costs per person vaccinated with 2-doses, ranged from $4.
28-$3.
29 in the 30% and 100% coverage strategies: While the economic delivery costs were two to three times higher than the financial costs.
The total procurement and delivery costs per person vaccinated with 2-doses ranged from $7.
34-$16.
47 for the financial costs and $29.
7-$24.
68 for the economic costs for the 30% and 100% coverage respectively.
With the exception of procurement costs, the main cost driver of financial and economic delivery costs was supply chain costs (47-59%) and advocacy, communication and social mobilization (29-35%) respectively.
Conclusion This analysis presents cost estimates that can be used to inform local policy and may further inform parameters used in cost-effectiveness models.
The results could potentially be adapted and adjusted to country-specific assumptions to enhance applicability in similar low-and middle-income settings.

Related Results

Differences in Immunoglobin a Levels in Breast Milk Between Mothers with and without the Covid 19 Vaccine
Differences in Immunoglobin a Levels in Breast Milk Between Mothers with and without the Covid 19 Vaccine
Giving the vaccine to breastfeeding mothers will provide immunity to the baby through the placenta, umbilical cord (IgG) and breast milk (IgA). The purpose of this study was to ana...
PERSEPSI IBU HAMIL TENTANG VAKSIN COVID-19 TERHADAP PELAKSANAAN VAKSINASI COVID-19
PERSEPSI IBU HAMIL TENTANG VAKSIN COVID-19 TERHADAP PELAKSANAAN VAKSINASI COVID-19
Latar Belakang: kasus positif Covid-19 di Kabupaten Sukoharjo tahun 2021 mencapai 12.350 dan terus mengalami penambahan jumlah. Dari jumlah tersebut terdapat 168 kasus positif Covi...
COVID-19 vaccine hesitancy among adults in Hawassa City Administration, Sidama Region, Ethiopia: A community-based study
COVID-19 vaccine hesitancy among adults in Hawassa City Administration, Sidama Region, Ethiopia: A community-based study
ObjectiveThe COVID-19 vaccine is one of the key measures to control the disease. However, some people are hesitant to take the vaccine. The objective of this study was to assess CO...
Attitudes towards COVID-19 vaccination, vaccine hesitancy and intention to take the vaccine
Attitudes towards COVID-19 vaccination, vaccine hesitancy and intention to take the vaccine
Background: The pandemic is at a paradoxical stage, with vaccine roll out initiated but a significantly elevated level of infection and death. Hope for recovery lies in high equita...
COVID-19 vaccine hesitancy among Tunisian cancer patients in the Salah Azaeiz Institute of Cancer
COVID-19 vaccine hesitancy among Tunisian cancer patients in the Salah Azaeiz Institute of Cancer
Abstract Background Vaccination against SARS-CoV-2 is the most effective way to stop the pandemic and to avoid its related death...
Social-Cyber Maneuvers During the COVID-19 Vaccine Initial Rollout: Content Analysis of Tweets (Preprint)
Social-Cyber Maneuvers During the COVID-19 Vaccine Initial Rollout: Content Analysis of Tweets (Preprint)
BACKGROUND During the time surrounding the approval and initial distribution of Pfizer-BioNTech’s COVID-19 vaccine, large numbers of social media users took...
Peter Chew Formular for calculate Covid-19 Vaccine efficiency
Peter Chew Formular for calculate Covid-19 Vaccine efficiency
Abstract Background: The World Health Organization (WHO) said the situation in India was a "devastating reminder" of what the coronavirus could do. India shifts from mass v...

Back to Top